longbridge

Craig-Hallum Sticks to Their Buy Rating for PMV Pharmaceuticals (PMVP)

Tip Ranks

Craig-Hallum analyst reiterated a Buy rating on PMV Pharmaceuticals today and set a price target of $4.00. In a report released today, Evercore ISI also maintained a Buy rating on the stock with a $4.00 price target.

Craig-Hallum analyst reiterated a Buy rating on PMV Pharmaceuticals today and set a price target of $4.00.

In a report released today, Evercore ISI also maintained a Buy rating on the stock with a $4.00 price target.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

© 2026 Longbridge｜Terms of ServicePrivacy Policy